The probability of new major cardiovascular events (MCVEs) in patients after an acute myocardial infarction depends on different variables, such as the time elapsed after the first event, the presentation scenario (acute coronary syndrome with/without ST elevation) and the associated risk factors.These events have been related to a persistent proinflammatory response, 1 platelet activity and thrombin activity. 2The arrival of medications with stronger and more specific antithrombotic activity at key points in the thrombotic process has permitted the assessment of their effects in the intensive antithrombotic secondary prevention scenario after the first year following a myocardial infarction. 3arious therapeutic strategies have been proposed in this type of prevention, including the extension of dual antiplatelet therapy (DAT), 4 beginning additional